Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Koss

Showing results (101-110 of 147) with videos related to

Pageof 15
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|August 22, 2017
Brief Report: Lopinavir Hair Concentrations Are the Strongest Predictor of Viremia in HIV-Infected Asian Children and Adolescents on Second-Line Antiretroviral TherapyJillian Pintye, Peter Bacchetti, Sirinya Teeraananchai, et al.
Clinical Pharmacology and Therapeutics|February 11, 2017
Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria ChemopreventionR Kajubi, L Huang, P Jagannathan, et al.
Journal of the International AIDS Society|July 6, 2023
Uptake of a patient-centred dynamic choice model for HIV prevention in rural Kenya and Uganda: SEARCH SAPPHIRE studyJane Kabami, Elijah Kakande, Gabriel Chamie, et al.
AIDS (London, England)|August 24, 2017
Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men/transwomenMonica Gandhi, Pamela M Murnane, Peter Bacchetti, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 15, 2024
Randomized Trial of Dynamic Choice HIV Prevention at Antenatal and Postnatal Care Clinics in Rural Uganda and KenyaJane Kabami, Catherine A Koss, Helen Sunday, et al.
Eclinicalmedicine|March 26, 2019
Development and Validation of an Immunoassay for Tenofovir in Urine as a Real-Time Metric of Antiretroviral AdherenceMonica Gandhi, Peter Bacchetti, Warren C Rodrigues, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 30, 2014
Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapyCatherine A Koss, Paul Natureeba, Albert Plenty, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 15, 2017
Estradiol Levels Are Altered in Human Immunodeficiency Virus-Infected Pregnant Women Randomized to Efavirenz-Versus Lopinavir/Ritonavir-Based Antiretroviral TherapyChloe R McDonald, Andrea L Conroy, Joel L Gamble, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2008
Comparative structure-activity relationship studies of 1-(5-methylsulfonylpyrid-2-yl)-5-alkyl and (hetero)aryl triazoles and pyrazoles in canine COX inhibitionSubas M Sakya, Andrei Shavnya, Hengmiao Cheng, et al.
AIDS (London, England)|October 22, 2019
Comparison of guidelines for HIV viral load monitoring among pregnant and breastfeeding women in sub-Saharan AfricaMaia Lesosky, Janet M Raboud, Tracy Glass, et al.
Pageof 15

Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
Journal of Acquired Immune Deficiency Syndromes (1999)|August 22, 2017
Brief Report: Lopinavir Hair Concentrations Are the Strongest Predictor of Viremia in HIV-Infected Asian Children and Adolescents on Second-Line Antiretroviral TherapyJillian Pintye, Peter Bacchetti, Sirinya Teeraananchai, et al.
Clinical Pharmacology and Therapeutics|February 11, 2017
Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria ChemopreventionR Kajubi, L Huang, P Jagannathan, et al.
Journal of the International AIDS Society|July 6, 2023
Uptake of a patient-centred dynamic choice model for HIV prevention in rural Kenya and Uganda: SEARCH SAPPHIRE studyJane Kabami, Elijah Kakande, Gabriel Chamie, et al.
AIDS (London, England)|August 24, 2017
Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men/transwomenMonica Gandhi, Pamela M Murnane, Peter Bacchetti, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 15, 2024
Randomized Trial of Dynamic Choice HIV Prevention at Antenatal and Postnatal Care Clinics in Rural Uganda and KenyaJane Kabami, Catherine A Koss, Helen Sunday, et al.
Eclinicalmedicine|March 26, 2019
Development and Validation of an Immunoassay for Tenofovir in Urine as a Real-Time Metric of Antiretroviral AdherenceMonica Gandhi, Peter Bacchetti, Warren C Rodrigues, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 30, 2014
Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapyCatherine A Koss, Paul Natureeba, Albert Plenty, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 15, 2017
Estradiol Levels Are Altered in Human Immunodeficiency Virus-Infected Pregnant Women Randomized to Efavirenz-Versus Lopinavir/Ritonavir-Based Antiretroviral TherapyChloe R McDonald, Andrea L Conroy, Joel L Gamble, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2008
Comparative structure-activity relationship studies of 1-(5-methylsulfonylpyrid-2-yl)-5-alkyl and (hetero)aryl triazoles and pyrazoles in canine COX inhibitionSubas M Sakya, Andrei Shavnya, Hengmiao Cheng, et al.
AIDS (London, England)|October 22, 2019
Comparison of guidelines for HIV viral load monitoring among pregnant and breastfeeding women in sub-Saharan AfricaMaia Lesosky, Janet M Raboud, Tracy Glass, et al.
Pageof 15